Jennifer W Kahende1, Trevor A Woollery, Chung-won Lee. 1. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA 30341, USA. JKahende@cdc.gov
Abstract
OBJECTIVE: To examine the current-period cost of treating 4 major smoking-related diseases: lung cancer, chronic obstructive pulmonary disease, ischemic heart disease, and cerebrovascular disease. METHODS: Analyses are based on the MarketScan database, a medical claims database from large employers. RESULTS: We found that total expenditures to treat ischemic heart disease were highest, followed by those to treat chronic obstructive pulmonary disease (COPD). When median expenditures per claim and disease severity were considered, lung cancer was the most expensive condition to treat and ischemic heart disease the least expensive. Median treatment expenditures increased as the severity of disease increased. CONCLUSION: Treating smoking-related diseases is costly in the current-period and over a lifetime.
OBJECTIVE: To examine the current-period cost of treating 4 major smoking-related diseases: lung cancer, chronic obstructive pulmonary disease, ischemic heart disease, and cerebrovascular disease. METHODS: Analyses are based on the MarketScan database, a medical claims database from large employers. RESULTS: We found that total expenditures to treat ischemic heart disease were highest, followed by those to treat chronic obstructive pulmonary disease (COPD). When median expenditures per claim and disease severity were considered, lung cancer was the most expensive condition to treat and ischemic heart disease the least expensive. Median treatment expenditures increased as the severity of disease increased. CONCLUSION: Treating smoking-related diseases is costly in the current-period and over a lifetime.
Authors: Sundar S Shrestha; Xin Xu; Xu Wang; Stephen D Babb; Brian S Armour; Brian A King; Katrina F Trivers Journal: Public Health Rep Date: 2021-02-18 Impact factor: 2.792
Authors: Jennifer W Kahende; Bishwa Adhikari; Emmanuel Maurice; Valerie Rock; Ann Malarcher Journal: Int J Environ Res Public Health Date: 2009-03-13 Impact factor: 3.390
Authors: Margaret A Olsen; Katelin B Nickel; Julie A Margenthaler; Ida K Fox; Kelly E Ball; Daniel Mines; Anna E Wallace; Graham A Colditz; Victoria J Fraser Journal: Ann Surg Oncol Date: 2016-01-28 Impact factor: 5.344